Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06902584 · ClinicalTrials.gov registry record

North American Comfilcon A Clinical Study

A clinical trial of Presbyopia and Astigmatism, sponsored by CooperVision International Limited (CVIL).

Recruiting
Registry status
182
Enrollment target
4
Study locations

NCT06902584 is a study of Presbyopia and Astigmatism that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 182 participants, below the 266-participant average among 38 other Presbyopia trials with a reported enrollment target (32% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06902584, a study of Presbyopia and Astigmatism, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).

RECRUITING
Registry status
182 participants
Enrollment target
4
Study locations

Study Summary

The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.

Interventions

  • DEVICE comfilcon A Sphere lens
  • DEVICE comfilcon A Toric lens
  • DEVICE comfilcon A Multifocal lens
  • DEVICE comfilcon A Multifocal Toric lens
  • DEVICE comfilcon A Energys lens

Study Locations (4)

California

  • University of Berkeley - Berkeley

Ohio

  • ProCare Vision Center - Granville

Pennsylvania

  • Nittany Eye Associates - College

Texas

  • Drs. McIntyre, Garza, Avila and Jurica, Optometrists - Corpus Christi

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2025-02-05
Est. Completion 2025-12

What the Registry Record Tells You About NCT06902584

The ClinicalTrials.gov registry entry for NCT06902584 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 38 other Presbyopia trials with a reported enrollment target (32% lower). The listed sponsor is CooperVision International Limited (CVIL), which has 11 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Presbyopia appearing as the primary indexed condition, and to 5 interventions - of which comfilcon A Sphere lens is the first listed.

NCT06902584 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06902584 about?

NCT06902584 is a clinical study titled "North American Comfilcon A Clinical Study". The main objective of this study is to demonstrate acceptable safety and effectiveness (performance) of comfilcon A Sphere, Toric, Multifocal, Toric Multifocal and Energys lenses, when used in the general population.

What is the current status of trial NCT06902584?

This trial is currently recruiting. The enrollment target is 182 participants. The study started on 2025-02-05. Estimated completion is 2025-12.

What conditions does trial NCT06902584 study?

This clinical trial studies the following conditions: Presbyopia, Astigmatism, Ametropia.

What interventions are being tested in trial NCT06902584?

The interventions under investigation include: comfilcon A Sphere lens (DEVICE), comfilcon A Toric lens (DEVICE), comfilcon A Multifocal lens (DEVICE), comfilcon A Multifocal Toric lens (DEVICE), comfilcon A Energys lens (DEVICE).

Who is sponsoring clinical trial NCT06902584?

This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06902584 being conducted?

This trial has 4 study locations across California, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.